Tocilizumab 162mg/0.9ml solution for injection pre-filled disposable devices
NHS hospitals in England used £61,979,846 of indicative cost of Tocilizumab 162mg/0.9ml solution for injection pre-filled disposable devices in the 12 months to April 2026, about 0.2% of all hospital medicines spend. That is up 27.2% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Tocilizumab 162mg/0.9ml solution for injection pre-filled disposable devices: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Tocilizumab 162mg/0.9ml solution for injection pre-filled disposable devices most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Royal Free London Nhs Foundation Trust | £1,692,011 |
| Manchester University Nhs Ft | £1,637,909 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £1,528,563 |
| Leeds Teaching Hpls Nhs Trust | £1,526,508 |
| Aintree University Hospital Nhs Ft | £1,521,943 |
| Portsmouth Hospitals Nhs Trust | £1,495,919 |
| King's College Hpl Nhs Foundation Trust | £1,214,906 |
| University Hpls Of Leicester Nhs Trust | £1,199,155 |
| Nottingham University Hospitals Trust | £1,193,904 |
| Gloucestershire Hpls Nhs Foundation Trst | £1,177,012 |
The primary-care picture
Tocilizumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Tocilizumab medicine page.